Creating a Paradigm for Biomarker TestingVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. Goeffrey Oxnard and Lauren Ritterhouse consider the advantages and disadvantages of liquid biopsies as an early screening tool for biomarker testing, and how to integrate various approaches into a biomarker testing paradigm.
Dr. S. Yosuf Zafar provides an overview of the advancement of precision medicine and points out the importance of making sure treatment decisions are in line with the patient’s goals.
The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Dr Lawrence Weiss, Medical Director at Clarient Diagnostic Services, discussing personalized medicine in diagnostics and with MultiOmyx™.